The Funding of Biopharmaceutical Research and Development

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology
Cover of the book The Funding of Biopharmaceutical Research and Development by David R Williams, Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: David R Williams ISBN: 9781908818386
Publisher: Elsevier Science Publication: October 31, 2013
Imprint: Woodhead Publishing Language: English
Author: David R Williams
ISBN: 9781908818386
Publisher: Elsevier Science
Publication: October 31, 2013
Imprint: Woodhead Publishing
Language: English

The funding of biopharmaceutical research and development provides a comprehensive critical review of the funding of research and development (R&D) in the human biopharmaceutical market sector. It addresses both private and public funding sources available in the US and internationally. The biopharmaceutical market is among the most research-intensive market sectors globally. Clinical researchers face a multitude of public and private funding options with respect to bringing their idea or innovation to market. These funding options are continually changing and complex, and are expected to decrease in the near future. A lack of understanding of the scale, scope, and inner workings of the funding aspects of R&D can, at times, act as a barrier for all involved, and can slow down or even eliminate the R&D process. The book lessens these barriers by describing the theoretical underpinnings, present practice, and trends in R&D funding in this market sector, both in the US and internationally. This includes a review and discussion of public-private partnership activity and their inner-workings, noting the complementary relationship between public and private funding. The book also contains an overview of the inner-workings of strategic alliance activity, including the advantages and disadvantages for each party. It goes on to provide an outline of venture capital activity, detailing the methods by which venture capital firms raise capital and are organized, a description of the venture capital-entrepreneur arrangement, and the effects of this arrangement. The book also presents an overview of the IPO process and the various fates of firms going public.

  • Presents a comprehensive view of the funding issues of R&D in this market sector, adopting a theory-to-practice approach
  • A comprehensive and analytical review of the biopharmaceutical R&D literature and practice
  • An overview of the various and competing/complementary theories of the firm and valuation methods as they apply to biopharmaceutical R&D
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The funding of biopharmaceutical research and development provides a comprehensive critical review of the funding of research and development (R&D) in the human biopharmaceutical market sector. It addresses both private and public funding sources available in the US and internationally. The biopharmaceutical market is among the most research-intensive market sectors globally. Clinical researchers face a multitude of public and private funding options with respect to bringing their idea or innovation to market. These funding options are continually changing and complex, and are expected to decrease in the near future. A lack of understanding of the scale, scope, and inner workings of the funding aspects of R&D can, at times, act as a barrier for all involved, and can slow down or even eliminate the R&D process. The book lessens these barriers by describing the theoretical underpinnings, present practice, and trends in R&D funding in this market sector, both in the US and internationally. This includes a review and discussion of public-private partnership activity and their inner-workings, noting the complementary relationship between public and private funding. The book also contains an overview of the inner-workings of strategic alliance activity, including the advantages and disadvantages for each party. It goes on to provide an outline of venture capital activity, detailing the methods by which venture capital firms raise capital and are organized, a description of the venture capital-entrepreneur arrangement, and the effects of this arrangement. The book also presents an overview of the IPO process and the various fates of firms going public.

More books from Elsevier Science

Cover of the book Applications of Targeted Nano Drugs and Delivery Systems by David R Williams
Cover of the book Patterning and Cell Type Specification in the Developing CNS and PNS by David R Williams
Cover of the book Exposure Science by David R Williams
Cover of the book Enhancing Learning and Teaching Through Student Feedback in Medical and Health Sciences by David R Williams
Cover of the book The Pituitary by David R Williams
Cover of the book Advances in Agronomy by David R Williams
Cover of the book Photobioreaction Engineering by David R Williams
Cover of the book Ordered Porous Solids by David R Williams
Cover of the book Fundamentals of Renewable Energy Processes by David R Williams
Cover of the book Hip Disorders in Children by David R Williams
Cover of the book Video Coding for Mobile Communications by David R Williams
Cover of the book Library Technology and User Services by David R Williams
Cover of the book Dislocations in Solids by David R Williams
Cover of the book Design and Evaluation of Physical Protection Systems by David R Williams
Cover of the book Antimicrobial Textiles by David R Williams
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy